Literature DB >> 34783938

Psychosocial Interventions to Promote Undetectable HIV Viral Loads: A Systematic Review of Randomized Clinical Trials.

Forrest Toegel1,2, Andrew M Rodewald1, Matthew D Novak1, Sarah Pollock1, Meghan Arellano1, Jeannie-Marie Leoutsakos1, August F Holtyn1, Kenneth Silverman3,4.   

Abstract

Suppressing HIV viral loads to undetectable levels is essential for ending the HIV/AIDS epidemic. We evaluated randomized controlled trials aimed to increase antiretroviral medication adherence and promote undetectable viral loads among people living with HIV through November 22, 2019. We extracted data from 51 eligible interventions and analyzed the results using random effects models to compare intervention effects between groups within each intervention and across interventions. We also evaluated the relation between publication date and treatment effects. Only five interventions increased undetectable viral loads significantly. As a whole, the analyzed interventions were superior to Standard of Care in promoting undetectable viral loads. Interventions published more recently were not more effective in promoting undetectable viral loads. No treatment category consistently produced significant increases in undetectable viral loads. To end the HIV/AIDS epidemic, we should use interventions that can suppress HIV viral loads to undetectable levels.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  AIDS; Adherence intervention; HIV; HIV viral load; Undetectable

Mesh:

Substances:

Year:  2021        PMID: 34783938      PMCID: PMC9050821          DOI: 10.1007/s10461-021-03534-z

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  64 in total

1.  Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes.

Authors:  Julio S G Montaner; Evan Wood; Thomas Kerr; Viviane Lima; Rolando Barrios; Kate Shannon; Richard Harrigan; Robert Hogg
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

2.  Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study.

Authors:  R Chris Rathbun; Kevin C Farmer; Johnny R Stephens; Staci M Lockhart
Journal:  Clin Ther       Date:  2005-02       Impact factor: 3.393

3.  Effectiveness of interventions for unstable patients on antiretroviral therapy in South Africa: results of a cluster-randomised evaluation.

Authors:  Matthew P Fox; Sophie J S Pascoe; Amy N Huber; Joshua Murphy; Mokgadi Phokojoe; Marelize Gorgens; Sydney Rosen; David Wilson; Yogan Pillay; Nicole Fraser-Hurt
Journal:  Trop Med Int Health       Date:  2018-10-24       Impact factor: 2.622

4.  Noninferiority of a task-shifting HIV care and treatment model using peer counselors and nurses among Ugandan women initiated on ART: evidence from a randomized trial.

Authors:  Flavia M Kiweewa; Deo Wabwire; Jessica Nakibuuka; Mike Mubiru; Danstan Bagenda; Phillippa Musoke; Mary G Fowler; Gretchen Antelman
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-01       Impact factor: 3.731

5.  Community-Based Accompaniment with Supervised Antiretrovirals for HIV-Positive Adults in Peru: A Cluster-Randomized Trial.

Authors:  Megan M McLaughlin; Molly F Franke; Maribel Muñoz; Adrianne K Nelson; Olga Saldaña; Janeth Santa Cruz; Milagros Wong; Zibiao Zhang; Leonid Lecca; Eduardo Ticona; Jorge Arevalo; Eduardo Sanchez; Jose Luis Sebastián; Sonya Shin
Journal:  AIDS Behav       Date:  2018-01

6.  Defining a Cutoff for Atazanavir in Hair Samples Associated With Virological Failure Among Adolescents Failing Second-Line Antiretroviral Treatment.

Authors:  Tariro D Chawana; Monica Gandhi; Kusum Nathoo; Bernard Ngara; Alexander Louie; Howard Horng; David Katzenstein; John Metcalfe; Charles F B Nhachi
Journal:  J Acquir Immune Defic Syndr       Date:  2017-09-01       Impact factor: 3.731

7.  Efficacy of an individualized adherence support program with contingent reinforcement among nonadherent HIV-positive patients: results from a randomized trial.

Authors:  Marjan Javanbakht; Paul Prosser; Tim Grimes; Michael Weinstein; Charles Farthing
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2006-12

8.  Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial.

Authors:  Frederick L Altice; Duncan Smith-Rohrberg Maru; R Douglas Bruce; Sandra A Springer; Gerald H Friedland
Journal:  Clin Infect Dis       Date:  2007-08-13       Impact factor: 9.079

9.  A Randomized Controlled Trial of Personalized Text Message Reminders to Promote Medication Adherence Among HIV-Positive Adolescents and Young Adults.

Authors:  Robert Garofalo; Lisa M Kuhns; Anna Hotton; Amy Johnson; Abigail Muldoon; Dion Rice
Journal:  AIDS Behav       Date:  2016-05

10.  Feasibility and Acceptability of a Task-Shifted Intervention to Enhance Adherence to HIV Medication and Improve Depression in People Living with HIV in Zimbabwe, a Low Income Country in Sub-Saharan Africa.

Authors:  Melanie Abas; Primrose Nyamayaro; Tarisai Bere; Emily Saruchera; Nomvuyo Mothobi; Victoria Simms; Walter Mangezi; Kirsty Macpherson; Natasha Croome; Jessica Magidson; Azure Makadzange; Steven Safren; Dixon Chibanda; Conall O'Cleirigh
Journal:  AIDS Behav       Date:  2018-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.